For many people, injection needles can be scary – and the larger ones for specialized longer-term medications are far more ...
2d
Daily Maverick on MSNExcitement builds for long-acting TB treatments, but research still at early stageBoth TB treatment and TB preventive therapy involve taking lots of pills, usually for several months. Researchers are working ...
With crucial lessons learned from the manufacturing shortages of injectable GLP-1s, experts say securing adequate supply for ...
Theratechnologies (THTX) announced that the FDA has approved the Company’s supplemental Biologics License Application, or sBLA, for the F8 ...
2d
News-Medical.Net on MSNNew MIT method promises less painful drug injections with tiny crystalsMIT engineers have devised a new way to deliver certain drugs in higher doses with less pain, by injecting them as a ...
New, improved formulation set to replace EGRIFTA SV®MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or ...
Engineers devised a way to deliver drugs such as contraceptives by injecting them as suspended crystals. Once under the skin, the crystals assemble into a drug depot that can last for months or years, ...
Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...
The new formula will replace EGRIFTA SV and treat excess visceral abdominal fat in adults with HIV and Lipodystrophy.
8hon MSN
Merck (MRK) released phase III data for an injection form of its blockbuster cancer treatment drug Keytruda and announced the FDA is reviewing the application for approval. The data showed that when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results